Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?

Background: Cytokeratin 19-positive (CK19(+)) hepatocellular carcinomas (HCC) are generally associated with poor prognosis after hepatectomy. It is typically detected from postoperative immunochemistry. We have analyzed several clinically available biomarkers, in particular, neutrophil to lymphocyte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chao-Wei Lee, Sey-En Lin, Ming-Chin Yu, Hao-Wei Kou, Cheng-Han Lee, Tony Kuo, Kuan-Chieh Lee, Hsin-I Tsai
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
NLR
R
Acceso en línea:https://doaj.org/article/a95080fe17b74e3cad83ec35b9eacc90
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a95080fe17b74e3cad83ec35b9eacc90
record_format dspace
spelling oai:doaj.org-article:a95080fe17b74e3cad83ec35b9eacc902021-11-25T18:06:57ZDoes Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?10.3390/jpm111110782075-4426https://doaj.org/article/a95080fe17b74e3cad83ec35b9eacc902021-10-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1078https://doaj.org/toc/2075-4426Background: Cytokeratin 19-positive (CK19(+)) hepatocellular carcinomas (HCC) are generally associated with poor prognosis after hepatectomy. It is typically detected from postoperative immunochemistry. We have analyzed several clinically available biomarkers, in particular, neutrophil to lymphocyte ratio (NLR) and aim to develop a panel of biomarkers in identifying CK19 expression in (HCC) preoperatively. Methods: We retrospectively reviewed 36 HCC patients who underwent liver resections during January 2017 to March 2018 in Chang Gung Memorial Hospital. Patients were grouped based on the status of CK19 expression and their baseline characteristics, perioperative and oncologic outcomes were compared. Novel biomarkers including NLR, alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) and uric acid were analyzed and correlated with CK19 expression. Results: NLR is highly associated with CK19 expression. NLR alone gave an AUROC of 0.728 (<i>p</i>-value = 0.043), higher than AFP, CEA or tumor size alone. NLR when combined with AFP, CEA and uric acid, gave an AUROC as high as 0.933 (<i>p</i>-value = 0.004). Conclusion: The current study demonstrated the predictive capability of NLR in combination with AFP, CEA and uric acid for CK19 expression in HCC patients preoperatively. Further prospective, large-scale studies are warranted to validate our findings.Chao-Wei LeeSey-En LinMing-Chin YuHao-Wei KouCheng-Han LeeTony KuoKuan-Chieh LeeHsin-I TsaiMDPI AGarticleneutrophil to lymphocyte ratioNLRhepatocellular carcinomahepatomacytokeratin 19 (CK19)MedicineRENJournal of Personalized Medicine, Vol 11, Iss 1078, p 1078 (2021)
institution DOAJ
collection DOAJ
language EN
topic neutrophil to lymphocyte ratio
NLR
hepatocellular carcinoma
hepatoma
cytokeratin 19 (CK19)
Medicine
R
spellingShingle neutrophil to lymphocyte ratio
NLR
hepatocellular carcinoma
hepatoma
cytokeratin 19 (CK19)
Medicine
R
Chao-Wei Lee
Sey-En Lin
Ming-Chin Yu
Hao-Wei Kou
Cheng-Han Lee
Tony Kuo
Kuan-Chieh Lee
Hsin-I Tsai
Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
description Background: Cytokeratin 19-positive (CK19(+)) hepatocellular carcinomas (HCC) are generally associated with poor prognosis after hepatectomy. It is typically detected from postoperative immunochemistry. We have analyzed several clinically available biomarkers, in particular, neutrophil to lymphocyte ratio (NLR) and aim to develop a panel of biomarkers in identifying CK19 expression in (HCC) preoperatively. Methods: We retrospectively reviewed 36 HCC patients who underwent liver resections during January 2017 to March 2018 in Chang Gung Memorial Hospital. Patients were grouped based on the status of CK19 expression and their baseline characteristics, perioperative and oncologic outcomes were compared. Novel biomarkers including NLR, alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) and uric acid were analyzed and correlated with CK19 expression. Results: NLR is highly associated with CK19 expression. NLR alone gave an AUROC of 0.728 (<i>p</i>-value = 0.043), higher than AFP, CEA or tumor size alone. NLR when combined with AFP, CEA and uric acid, gave an AUROC as high as 0.933 (<i>p</i>-value = 0.004). Conclusion: The current study demonstrated the predictive capability of NLR in combination with AFP, CEA and uric acid for CK19 expression in HCC patients preoperatively. Further prospective, large-scale studies are warranted to validate our findings.
format article
author Chao-Wei Lee
Sey-En Lin
Ming-Chin Yu
Hao-Wei Kou
Cheng-Han Lee
Tony Kuo
Kuan-Chieh Lee
Hsin-I Tsai
author_facet Chao-Wei Lee
Sey-En Lin
Ming-Chin Yu
Hao-Wei Kou
Cheng-Han Lee
Tony Kuo
Kuan-Chieh Lee
Hsin-I Tsai
author_sort Chao-Wei Lee
title Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
title_short Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
title_full Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
title_fullStr Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
title_full_unstemmed Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
title_sort does neutrophil to lymphocyte ratio have a role in identifying cytokeratin 19-expressing hepatocellular carcinoma?
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/a95080fe17b74e3cad83ec35b9eacc90
work_keys_str_mv AT chaoweilee doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma
AT seyenlin doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma
AT mingchinyu doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma
AT haoweikou doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma
AT chenghanlee doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma
AT tonykuo doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma
AT kuanchiehlee doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma
AT hsinitsai doesneutrophiltolymphocyteratiohavearoleinidentifyingcytokeratin19expressinghepatocellularcarcinoma
_version_ 1718411634958925824